NDAC
This article was originally published in The Tan Sheet
Executive Summary
Committee charter renewed for two years, expiring Aug. 27, 2001. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7 and 9. The FDA committee's last scheduled 1999 meeting, Dec. 2-3, was canceled for lack of agenda items (1"The Tan Sheet" Oct. 25, In Brief)
You may also be interested in...
NDAC
Last scheduled 1999 meeting, Dec. 2-3, has been canceled due to lack of agenda items. Tentative meeting dates for 2000 are Feb. 28-29, June 22-23, Oct. 19-20 and Dec. 7-8. NDAC last met on July 20 with the Arthritis Advisory Committee to consider the Rx-to-OTC switch of Merck's Flexeril 5 mg (1"The Tan Sheet" July 26, pp. 3-9)
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands